Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

被引：51

作者：

Doehner, W

Anker, SD

机构：

[1] Dept Cardiol, Div Appl Cachexia Res, Charite Med Sch, D-13353 Berlin, Germany

[2] Univ London Imperial Coll Sci & Technol, Natl Heart & Lung Inst, Dept Clin Cardiol, London, England

来源：

HEART | 2005年 / 91卷 / 06期

关键词：

D O I：

10.1136/hrt.2004.057190

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A substantial body of evidence has accumulated to suggest a role for the xanthine oxidase metabolic pathway in the pathophysiology of chronic heart failure and other cardiovascular diseases.

引用

页码：707 / 709

页数：3

共 32 条

[1] Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance [J].

Adams, V ;

Jiang, H ;

Yu, JT ;

Möbius-Winkler, S ;

Fiehn, E ;

Linke, A ;

Weigl, C ;

Schuler, G ;

Hambrecht, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (04) :959-965

[2] Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].

Anker, SD ;

Doehner, W ;

Rauchhaus, M ;

Sharma, R ;

Francis, D ;

Knosalla, C ;

Davos, CH ;

Cicoira, M ;

Shamim, W ;

Kemp, M ;

Segal, R ;

Osterziel, KJ ;

Leyva, F ;

Hetzer, R ;

Ponikowski, P ;

Coats, AJS .

CIRCULATION, 2003, 107 (15) :1991-1997

[3] When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid [J].

Bagnati, M ;

Perugini, C ;

Cau, C ;

Bordone, R ;

Albano, E ;

Bellomo, G .

BIOCHEMICAL JOURNAL, 1999, 340 :143-152

[4]

BAKHTIYAROV ZA, 1989, TERAPEVT ARKH, V61, P68

[5] Beta-blockers for chronic heart failure: surviving longer but feeling better? [J].

Bolger, AP ;

Al-Nasser, F .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 92 (01) :1-8

[6] Tumour necrosis factor in chronic heart failure - A peripheral view on pathogenesis, clinical manifestations and therapeutic implications [J].

Bolger, AP ;

Anker, SD .

DRUGS, 2000, 60 (06) :1245-1257

[7] Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy [J].

Cappola, TP ;

Kass, DA ;

Nelson, GS ;

Berger, RD ;

Rosas, GO ;

Kobeissi, ZA ;

Marbán, E ;

Hare, JM .

CIRCULATION, 2001, 104 (20) :2407-2411

[8]

COGHLAN JG, 1994, J THORAC CARDIOV SUR, V107, P248

[9] Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies [J].

Doehner, W ;

Schoene, N ;

Rauchhaus, M ;

Leyva-Leon, F ;

Pavitt, DV ;

Reaveley, DA ;

Schuler, G ;

Coats, AJS ;

Anker, SD ;

Hambrecht, R .

CIRCULATION, 2002, 105 (22) :2619-2624

[10] Uric acid in cachectic and noncachectic patients with chronic heart failure: Relationship to leg vascular resistance [J].

Doehner, W ;

Rauchhaus, M ;

Florea, VG ;

Sharma, R ;

Bolger, AP ;

Davos, CH ;

Coats, AJS ;

Anker, SD .

AMERICAN HEART JOURNAL, 2001, 141 (05) :792-799

← 1 2 3 4 →